ACM
NVNO

Altium Capital Management’s enVVeno Medical NVNO Stock Holding History

Altium Capital Management’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,522
Closed -$324K – 11
2025
Q1 		$324K Sell
3,522
-5,335
-60% -$594K 0.78% 17
2024
Q4 		$936K Buy
8,857
+2,031
+30% +$227K 0.27% 55
2024
Q3 		$803K Buy
+6,826
New +$1.25M 0.24% 49
2024
Q1 		– Sell
-9,842
Closed -$1.77M – 86
2023
Q4 		$1.77M Buy
+9,842
New +$1.57M 1.2% 22

Other funds holding NVNO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $58.1B AUM 27.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Altium Capital Management's NVNO Position: Q2 2025 in Review

Altium Capital Management sold out of enVVeno Medical (NVNO) in Q2 2025, closing a stake of 3,522 shares — an estimated $324K sold.

Altium Capital Management first reported a position in NVNO in Q4 2023 and held it in 4 quarters. The position peaked at $1.77M in Q4 2023. 37 funds tracked by Wall St. Rank hold NVNO as of Q2 2025.

  • Altium Capital Management reported no remaining enVVeno Medical position as of Q2 2025 after selling out during the quarter.
  • Altium Capital Management sold 3,522 enVVeno Medical shares in Q2 2025, an estimated $324K.
  • Altium Capital Management first reported a position in enVVeno Medical in Q4 2023 and held it in 4 quarters.
  • Altium Capital Management's enVVeno Medical position peaked at $1.77M in Q4 2023.
  • 37 funds tracked by Wall St. Rank held enVVeno Medical as of Q2 2025.

Based on Altium Capital Management's 13F filing for Q2 2025.